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BY-NC-ND license (http://creativecomAbstract Objective: To explore the ability of Synechocystis sp. PCC6803 in transforming 6-
deoxypseudoanisatin.
Methods: The experiment was performed by incubating 6-deoxypseudoanisatin with the fresh-
water cyanobacterium Synechocystis sp. PCC6803 under continuous white light at 30C for 5
days. The crude converted product was detected using thin-layer chromatography (TLC) and
further analyzed using high-performance liquid chromatography (HPLC) as well as HPLC with
electron spray ionization mass spectrometry (HPLC-ESI-MS).
Results: TLC results showed that 6-deoxypseudoanisatin was converted into a less polar prod-
uct. HPLC and MS data indicated that the retention time of the converted product increased in
comparison with the standard of 6-deoxypseudoanisatin.
Conclusion: Thus, the study appears to demonstrate that Synechocystis sp. PCC6803 can trans-
form 6-deoxypseudoanisatin. The polarity of the converted product is less than that of 6-
deoxypseudoanisatin.
ª 2015 Beijing University of Chinese Medicine. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).Introduction
The sesquiterpene lactone 6-deoxypseudoanisatin, the mo-
lecular formula of which is C15H22O5 and the molecular
weight of which is 282.33 (Fig. 1), belongs to the pseudoa-
nisatin subtype of seco-prezizaane-type sesquiterpenes.1e38473 8646; fax: þ86 10 8473 86
m (C. Wang).
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mons.org/licenses/by-nc-nd/4.0/Although reports on its biological activity are few, its
characteristics such as its non-toxic property, sufficient
content in plants, and that it is easily extracted from
plants, makes it a desirable substrate to synthesize its
structurally similar compounds with desirable pharmaco-
logic activities. For example, Zhang et al.4 attempted to11.
dicine.
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Figure 1 Structure of 6-deoxypseudoanisatin.
Table 1 Gradient elution program for the converted
product.
Time (min) Water (%) Acetonitrile (%) Flow (mL/min)
0 98 2 1
5 85 15 1
5.5 85 15 0.5
24 84 16 0.5
25 80 20 1
60 30 70 0.5
Table 2 Mass spectroscopy parameters.
Range mode Ultra scan
Ion polarity Positive
Ion source type ESI
Dry temp (Set) 350C
Nebulizer (set) 40.00 psi
136 Z. Wang et al.use 6-deoxypseudoanisatin instead of its structurally similar
compound, pseudoanisatin, as a starting reactant for a se-
ries of chemical synthesis pathways to form merrilactone A,
which has remarkably apparent neurotrophic activity.
Though their efforts were unsuccessful, the potential of
using 6-deoxypseudoanisatin to produce compounds via the
effect of biologic reactors remains attractive. In this paper,
we report on the use of a biological reactor to modify and
transform 6-deoxypseudoanisatin to discover new com-
pounds with inspiring bioactivities.
Although far less is known about its role as a biological
reactor (bioreactor) than fungi, yeast, and other bacteria,
cyanobacteria have been used as a bioreactor for
biotransformation with some studies showing high trans-
formation efficiency.5,6 Cyanobacteria are microorganisms
that use ubiquitous sunlight as their energy source, and
some can even fix atmospheric nitrogen.7 Thus, their large-
scale culture can be simpler and cheaper than that of other
microorganisms. These important advantages give cyano-
bacteria great potential to be biocatalysts. Synechocystis
sp. PCC6803 is a well-studied cyanobacterium. In addition
to the general advantages of cyanobacteria, when used as a
biocatalyst the advantages of Synechocystis sp. PCC6803
include a clear genetic background, rapid growth rate,
simple structure, and abundant enzyme systems.8,9 More-
over, it can biotransform inorganic arsenic (As), that is,
methylate arsenic to different As species.10 However, its
ability to transform organic compounds has not been eval-
uated. Thus, we used Synechocystis sp. PCC6803 to trans-
form 6-deoxypseudoanisatin to confirm its ability as a
biocatalyst and obtain compounds with inspiring bioac-
tivity. We also performed thin-layer chromatography (TLC),
high-performance liquid chromatography (HPLC), and high-
performance liquid chromatography with electron spray
ionization mass spectrometry (HPLC-ESI-MS) to analyze the
converted product.Dry gas (set) 10.00 L/min
Scan begin 100 m/z
Scan end 1000 m/z
Averages 5 spectra
Trap drive 41.4
Octopole RF amplitude 152.8 Vpp
Capillary exit 113.5 V
Skimmer 40.0 V
Oct 1 DC 12.00 V
Oct 2 DC 1.70 V
Max. accu time 200 000 msec
Ion charge control target 200 000
Charge control OnMaterials and methods
The substrate 6-deoxypseudoanisatin was isolated from
Illicium macranthum according to the previous protocol
described by Ma et al.11 Synechocystis sp. PCC6803 was
kindly provided by Fang Huang (Institute of Botany, The
Chinese Academy of Sciences, Beijing, China). The cyano-
bacterium was cultivated in aseptic BG-11 liquid medium12
under 20 000 lx continuous white light at 30C. The medium
in the Erlenmeyer flask was incubated on a rotary shaker at
110 rpm. All chemicals were of analytic reagent grade.Biotransformation
Synechocystis sp. PCC6803 was aseptically transferred to
the BG-11 liquid medium for shake culture. When OD750 nm
was 0.4, 40 ml of a 6-deoxypseudoanisatin dimethyl sulf-
oxide solution (103 mg/mL) was mixed with 50 ml of me-
dium to perform the biotransformation experiment. The
entire transformation system was placed under 20 000 lx
continuous white light at 30C for 5 days on a rotary shaker
at 110 rpm. Two control experiments were performed
under identical culture conditions in the absence of either
Synechocystis sp. PCC6803 or 6-deoxypseudoanisatin. The
entire experiment was repeated 3 times to validate
reproducibility.
Extraction and isolation of the converted product
After 5 days of incubation, the alga suspension was placed
in an 80C ultra-low temperature refrigerator to freeze
for 4e12 h. The frozen mixture was then thawed in a 37C
water bath for 15e30 minutes. Repeated freezing and
thawing were performed 4 times before the next process.
The treated alga suspension was filtered through a 0.22-mm
mixed cellulose ester microporous filtration membrane.
The concentration of the filtrated aqueous solution was
approximately 0.08 mg/mL (calculated based on the
Figure 2 Transformation of 6-deoxypseudoanisatin by Syn-
echocystis sp. PCC6803, which was analyzed using TLC. 1:
standard of 6-deoxypseudoanisatin; 2: control group without 6-
deoxypseudoanisatin; 3: transformation group; 4: control
group without Synechocystis sp. PCC6803.
Biotransformation of 6-deoxypseudoanisatin 137concentration of 6-deoxypseudoanisatin). The control ex-
periments received identical treatment.
Analysis of the converted product
The filtered aqueous samples were first analyzed using thin-
layer chromatography (TLC) for preliminary validation of
the converted product. TLC was performed on precoated
silica gel G254 plates (Qingdao Haiyang Chemical Company,Figure 3 HPLC chromatograms of 6-deoxypseudoanisatin and its
deoxypseudoanisatin and its metabolites by Synechocystis sp. P
without Synechocystis sp. PCC6803; 3: Synechocystis sp. PCC6803 i
deoxypseudoanisatin control. All groups except group 4 were inc
identical treatment before HPLC analysis.Qingdao, Shandong, China). The TLC plates were visualized
with a 10% H2SO4eEtOH spray reagent and subsequently
heated. Petroleum ether/acetic ether (V/V, 4/6) was used
as the developing solvents.
The filtered aqueous samples were analyzed using
HPLC, which was performed on a Waters 2489 UV/Visible
detector (Waters Corporation, Milford, MA, USA) and a
Grace Apollo C18 Column (250 mm  4.6 mm, 5 mm) (W.R.
Grace & Co.-Conn, Columbia, MD, USA). The compounds
were eluted with a gradient of acetonitrile-water (2e70%
(v/v) acetonitrile) for over 60 minutes (Table 1). The
column temperature was room temperature. The samples
were detected at 200 nm. The sample injection volume
was 10 mL.
HPLC-ESI-MS analysis was performed on an Agilent Series
1100 HPLC Value System (Agilent Technologies, Waldbronn,
Germany) coupled with an Agilent 1100 MSD XCT/plus ion
trap mass spectrometer (Agilent) through an electrospray
ionization (ESI) interface. The HPLC instrument was
equipped with a quaternary pump, a diode-array detector,
an auto sampler, and a column compartment. The samples
were separated on an Agilent Zorbax SB-CN column
(250 mm  4.6 mm I.D., 5 mm), equipped with a Waters
Symmetry C18 guard column (20 mm  3.9 mm I.D., 5 mm).
The HPLC eluotropic program was identical to the previous
HPLC analysis (Table 1). For MS detection, positive ion po-
larity modes were used for compound ionization. High-
purity nitrogen (N2) was used as the nebulizing gas, and
ultra-high pure helium (He) was used as the collision gas.
Parameters were as follows: nebulizer pressure 40 psi;
capillary temperature 350 C; capillary voltage 113.5 V; and
dry gas flow rate 10 L/min (Table 2). For full scan MS
analysis, spectra were recorded in the range of (m/z)
100e1000.metabolites, produced using Synechocystis sp. PCC6803. 1: 6-
CC6803; 2: 6-deoxypseudoanisatin in a BG-11 liquid medium
n a BG-11 liquid medium without 6-deoxypseudoanisatin; 4: 6-
ubated in the BG-11 liquid medium for 5 days and received
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TLC analysis indicated that after 5 days of biotransformation
using Synechocystis sp. PCC6803, 6-deoxypseudoanisatin (Rf
value of 0.3) converted into a product with a higher Rf value
(0.4) and a lower polarity (Fig. 2). This satisfactory result
compelled us to perform a more precise analysis.
HPLC analysis showed a high peakwith a retention time of
approximately 21.5 minutes in all groups except the control
group without 6-deoxypseudoanisatin, and this peak should
be the peak of 6-deoxypseudoanisatin. There was also a
unique peak at approximately 27.5 minutes in the experi-
mental group. This result and the TLC result authenticate
the biotransformation of 6-deoxypseudoanisatin by Syn-
echocystis sp. PCC6803 (Fig. 3).
HPLC-ESIeMS analysis was then conducted to examine
the molecular weight of the converted product. In the MS
spectra, the peak at 21.5 minutes indicated a strong ion at
m/z 304.9 in the groups that contained 6-
deoxypseudoanisatin, which should be an [MþNa]þ ion ofFigure 4 MS spectra of 6-deoxypseudoanisatin (a) and the conve6-deoxypseudoanisatin. There were also ions at m/z 282.9
and 320.9, which should be the [MþH]þ and [MþK]þ ions of
6-deoxypseudoanisatin, respectively. In the MS spectrum of
the converted product with a retention time of 27.5 mi-
nutes, strong ions at m/z 282.9, 304.9 and 320.9 were also
observed. In addition, the two spectra showed great simi-
larity in other ions with only different intensities (Fig. 4).Discussion
Based on the TLC, HPLC, and MS data, 6-
deoxypseudoanisatin can be transformed under the effect
of Synechocystis sp. PCC6803. Three repetitive experiments
were performed to evaluate the reproducibility of this
biotransformation. The results were identical with one
another. Thus, this study demonstrates the capability of
Synechocystis sp. PCC6803 to transform seco-prezizaane-
type sesquiterpene. This finding deepens our understand-
ing of this well-studied model cyanobacterium, which inrted product (b).
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and photosynthesis studies, and appears to be an ideal
biocatalyst. Furthermore, the discovery of this trans-
formation system makes the biotransformation of natural
substrates a reality in easily cultivated cyanobacteria, and
the discovery of converted products of natural substrates
helps to enrich the structure spectrum of natural prod-
ucts.13 Finally, because some structurally unique sesqui-
terpenes, such as seco-prezizaane-type and anislactone-
type sesquiterpenes, exhibit fascinating neurotrophic ac-
tivity, the biotransformation of 6-deoxypseudoanisatin,
which is also a structurally unique seco-prezizaane-type
sesquiterpene and has high content in many Illicium spe-
cies, will aid in the discovery of new compounds with
intriguing neurotrophic activity for future use in the
treatment of Alzheimer disease and Parkinson.
The MS spectrum of the converted product appears
notably similar to that of 6-deoxypseudoanisatin. There are
two explanations for this similarity. First, the converted
product may be an isomer of 6-deoxypseudoanisatin, so
there are identical ions in both MS spectra. The other
explanation is that some fragile radical groups may have
combined with the structure of 6-deoxypseudoanisatin to
form the converted product and later dissociated from it
because of electron spray ionization.
In conclusion, our study demonstrates the ability of
Synechocystis sp. PCC6803 as a biocatalyst to transform 6-
deoxypseudoanisatin, which is a unique seco-prezizaane-
type sesquiterpene. The converted product has a lower
polarity than 6-deoxypseudoanisatin.Acknowledgments
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